Navigation Links
Alere Announces Preliminary Results Of Voting At Annual Meeting
Date:8/7/2013

WALTHAM, Mass., Aug. 7, 2013 /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company" or "Alere") today announced that, based on a preliminary count of votes cast at the Company's 2013 Annual Meeting of Stockholders held today, stockholders have elected all four of the Company's director nominees, Hakan Bjorklund, Stephen MacMillan, Brian Markison and Sir Thomas McKillop.

Alere issued the following statement:

"Alere's Board and management team appreciate the feedback we have received from our stockholders, and we extend our gratitude for their support of our independent director nominees. Our plan to improve organic revenue growth, drive higher operating margins and reduce leverage has been recognized. While we are pleased with our progress to date, this process has only further sharpened our commitment to delivering strong results.

"We look forward to benefitting from the unique operational experience and fresh perspectives of our new board members and building on our positive momentum as we continue to work to enhance stockholder value. We also look forward to our Board acting on the recommendation to appoint Gregg Powers, who our nominating committee believes can help guide our strategy and serve as another independent voice for stockholders on the Board."

The preliminary voting also indicated that stockholders approved all of the other proposals submitted for a vote at the Annual Meeting.

The meeting was adjourned to 12:30 p.m. on August 19, 2013 at The Emerging Enterprise Center at Foley Hoag LLP located at 1000 Winter Street, Suite 4000, Waltham, Massachusetts 02451, solely to receive the final report of IVS Associates, Inc., the independent inspector of elections. 

About Alere

By developing new capabilities in near-patient diagnosis, monitoring and health information technology, Alere enables individuals to take charge of improving their health and quality of life at home.  Alere's global leading products and services, as well as its new product development efforts, focus on cardiology, infectious disease, toxicology and diabetes.  Alere is headquartered in Waltham, Massachusetts. For more information regarding Alere please visit www.alere.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the outcome of the vote on each matter. These statements reflect our current views with respect to future events and are based on management's current assumptions and information currently available. Actual results may differ materially due to numerous factors including, without limitation, the independent inspector's final tabulation of voting results. We undertake no obligation to update any forward-looking statements contained herein.


'/>"/>
SOURCE Alere Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Alere Inc. Schedules Conference Call for 8:30 a.m. ET July 31, 2013 to Discuss Second Quarter 2013 Results
2. Alere Accountable Care Solutions to Provide Health Information Network to Childrens Care Alliance for Underserved Children
3. Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
4. Alere Inc. Announces Tender Offer and Consent Solicitation for Any and All of its 9.00% Senior Subordinated Notes due 2016
5. Alere Acquires Epocal, Inc.
6. Alere Inc. Announces Hiring of Namal Nawana as Chief Operating Officer
7. Alere Inc. Announces Early Results of its Tender Offer and Consent Solicitation for Any and All of its 7.875% Senior Notes due 2016
8. Alere Inc. Announces Offering of $450 Million of Senior Notes
9. Heska Announces Financial Results for the Second Quarter of Fiscal 2013
10. Ohr Pharmaceutical Announces Addition of Dr. John Wroblewski to Ophthalmic Scientific Advisory Board
11. FullCircle Registry, Inc. Announces Letter of Intent to Purchase Medical Supply Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with ... Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):